Kyverna became the first company this month to initiate a BLA for CAR-T to treat an autoimmune condition. CEO Warner Biddle describes Stiff Person Syndrome and what it means as PoC
- May 20
- 1 min read
He discusses the data from the registrational trial that was presented at AAN last month, and the timeline of the BLA. Plus, myasthenia gravis, which is already in a pivotal, and other conditions the company is considering.
.png){kind=logo}